OCEAN BIO-CHEM, INC (NASDAQ:OBCI) Files An 8-K Changes in Registrant’s Certifying Accountant

Item 4.01 that the requested letter from BDO USA, LLP, addressed
to the Securities and Exchange Commission and stating whether or
not it agrees with the certain statements in the initially filed
Form 8-K, is filed as Exhibit 16.1 to this Amendment No.1; (ii)
to add Item 9.01, noting the filing of the letter as Exhibit
16.1; and (iii) to include the letter as Exhibit 16.1 to this
Amendment No.1. Except as noted above, no modifications have been
made to the text of the initial filing on Form 8-K.

Item 4.01. Changes in Registrants Certifying
Accountant

On February 21, 2017, the Audit Committee of the Board of
Directors of Ocean Bio-Chem, Inc. (the Company) dismissed BDO
USA, LLP (BDO), as the Company’s independent registered public
accounting firm.

BDO was engaged by the Company on October 28, 2016 and did not
issue a report on the Companys consolidated financial statements
as of, and for the fiscal year ended, December 31, 2016. From
October 28, 2016 through February 21, 2017, there were no (i)
disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K
and related instructions) between the Company and BDO on any
matter of accounting principles or practices, financial statement
disclosure or auditing scope or procedure, which, if not resolved
to the satisfaction of BDO, would have caused BDO to make
reference to the subject matter of the disagreement in its
report; or (ii) reportable events, as defined in Item 304
(a)(1)(v) of Regulation S-K..

The Company has requested that BDO furnish it with a letter
addressed to the Securities and Exchange Commission stating
whether or not it agrees with the above statements. A copy of
that letter, dated February 23, 2017, is filed as Exhibit 16.1 to
this report.

On February 22, 2017, the Audit Committee of the Companys Board
of Directors engaged EisnerAmper LLP (EisnerAmper) as the
Companys independent registered public accounting firm to audit
the Companys financial statements as of, and for the fiscal year
ended, December 31, 2016. During the years ended December 31,
2015 and 2016, and the subsequent interim period through February
22, 2017, neither the Company nor anyone acting on its behalf has
consulted EisnerAmper regarding either (i) the application of
accounting principles to a specified transaction, either
completed or proposed, or the type of audit opinion that might be
rendered on the Companys financial statements; or (ii) any matter
that was the subject of a disagreement (as defined in Item
304(a)(1)(iv) of Regulation S-K and the related instructions) or
a reportable event (as that term is defined in Item 304(a)(1)(v)
of Regulation S-K).

Item 9.01. Financial Statements and Exhibits

The following exhibit is filed with this report:

About OCEAN BIO-CHEM, INC (NASDAQ:OBCI)

Ocean Bio-Chem, Inc. is engaged in the manufacturing, marketing and distribution of a range of appearance, performance and maintenance products. The Company offers its services under the Star brite and Star Tron brand names within the United States and Canada. In addition, the Company produces private label formulations of its products for various customers and provides custom blending and packaging services for these and other products. The Company is also engaged in manufacturing, marketing and distributing disinfectant, sanitizing and deodorizing products under the Performacide and Star brite brand names. The products that the Company manufactures and markets include marine, automotive, recreational vehicle/power sports, outdoor power equipment/lawn and garden, disinfectants, sanitizers and deodorizers, and contract filling and blow molded bottles. The Company produces its products at the manufacturing facilities of its subsidiary, Kinpak, Inc., in Montgomery, Alabama.

OCEAN BIO-CHEM, INC (NASDAQ:OBCI) Recent Trading Information

OCEAN BIO-CHEM, INC (NASDAQ:OBCI) closed its last trading session up +0.08 at 4.15 with 3,083 shares trading hands.